论文部分内容阅读
目的研究植入式方法静脉输液港在造血干细胞移植患者中的应用以及效果评价。方法选取2011年3月~2015年10月期间共进行造血干细胞移植92例患者作为观察对象,对其进行静脉输液港植入术。其中经锁骨下静脉穿刺58例,经颈内静脉穿刺34例,并给予规范化的护理及管理。结果 92例患者中,8例患者输液港穿刺点或底座周围皮肤处发生感染,占8.69%;2例患者手术切口出现皮下淤血,占2.17%;6例输液港出现输液不畅,占6.52%;1例出现完全堵管,占1.08%。结论论植入式静脉输液港在造血干细胞移植患者中的应用,能够减轻患者的痛苦,减少医护人员的工作量,减少并发症的发生,提高患者满意度,值得推广及应用。
Objective To study the application of implantable venous port in patients with hematopoietic stem cell transplantation and its effect evaluation. Methods A total of 92 patients undergoing hematopoietic stem cell transplantation from March 2011 to October 2015 were enrolled in this study. Among them, 58 cases were punctured by subclavian vein and 34 cases punctured by internal jugular vein, and standardized nursing and management were given. Results Among the 92 patients, 8 patients were infected at the transfusion site or the skin around the base, accounting for 8.69%. 2 patients had subcutaneous congestion at the surgical incision, accounting for 2.17% ; 1 case completely blocked tube, accounting for 1.08%. Conclusion The application of implantable venous transfusion port in patients with hematopoietic stem cell transplantation can reduce the pain of patients, reduce the workload of medical staff, reduce the incidence of complications, improve patient satisfaction, and worthy of promotion and application.